New data presented at ACC 2026 clarifies sotatercept’s role alongside vasodilator-based regimens in PAH patients.
KOLs note that CagriSema could cannibalise semaglutide's market share in obesity due to its improved efficacy.
New Meta-Analysis Reveals Biochar’s Role in Restoring Salt-Affected Soils New research provides critical insights into ...
New research from the University of Newcastle has found that people with irritable bowel syndrome (IBS) show detectable ...
The Brookbush Institute continues to enhance education with new articles, new courses, a modern glossary, an AI Tutor, ...
The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...